Skip to main content

Table 4 Per-lesion sensitivity to malignant lesions and false-positive marks per case using BI-RADS score of at least 4 to define a positive mark

From: Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study

Reader

MX ± US

MX ± US ± CEDM

Difference

Pvalue

Sensitivity

1

0.702 ± 0.050

0.762 ± 0.047

0.060

0.13

2

0.738 ± 0.048

0.81 ± 0.043

0.071

0.08

3

0.738 ± 0.048

0.845 ± 0.040

0.107

0.01

4

0.762 ± 0.047

0.821 ± 0.042

0.060

0.07

5

0.702 ± 0.05

0.738 ± 0.048

0.036

0.50

6

0.631 ± 0.053

0.690 ± 0.051

0.060

0.18

Overall

0.712 ± 0.043

0.778 ± 0.040

0.065 ± 0.024

0.006

95% CI

0.628 to 0.797

0.697 to 0.858

0.019 to 0.112

 

False-positive marks per case (cases without malignant lesions)

1

0.478 ± 0.056

0.652 ± 0.064

0.174

0.034

2

0.565 ± 0.056

0.435 ± 0.052

-0.130

0.128

3

0.652 ± 0.058

0.674 ± 0.067

0.022

0.745

4

1.043 ± 0.06

0.978 ± 0.065

-0.065

0.545

5

0.717 ± 0.052

0.609 ± 0.051

-0.108

0.134

6

0.478 ± 0.056

0.478 ± 0.063

0.000

1.000

Overall

0.656 ± 0.092

0.638 ± 0.089

-0.018 ± 0.050

0.726

95% CI

0.443 to 0.869

0.434 to 0.842

-0.135 to 0.099

 
  1. BI-RADS, Breast Imaging, Reporting and Data System; CEDM, contrast-enhanced digital mammography; CI, confidence interval; MX, mammography; US, ultrasonography.